Blog

Sarah Sammons: Join us for dinner and lively discussion on novel therapies for HR+ MBC

Photos of Sarah Sammons and Aditya Bardia from X and Virginia Kaklamani from sabcs.org

May 13, 2024, 09:09

Sarah Sammons: Join us for dinner and lively discussion on novel therapies for HR+ MBC

Sarah Sammons shared on X:

“Join Aditya Bardia, Virginia Kaklamani and I 6/1 for dinner and lively discussion on novel therapies for HR+ metastatic breast cancer. Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs at CCO.” .

Source: Sarah Sammons/X

Sarah Sammons is a medical oncologist at Dana-Farber’s Breast Oncology Center specializing in treating patients with all stages of breast cancer. She is particularly focusing on improving outcomes for those with metastatic breast cancer.

Through leading numerous clinical trials, she has developed new treatment options for breast cancer patients. Additionally, Dr. Sammons is skilled in treating brain metastases.

Aditya Bardia cancer CCO Dana-Farber’s Breast Oncology Center HR+/HER2- breast cancer MBC metastatic breast cancer OncoDaily Oncology Sarah Sammons SERDs Virginia Kaklamani

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage